JOURNAL OF COORDINATION CHEMISTRY
3
2.2.1. [PdCl2(IPr)(5-phenyl-1H-1,2,3-triazole)] (1)
The procedure yielded 125 mg (88%) of the product 1. 1H NMR (400 MHz, CDCl3):
δ (ppm) = 12.94 (s, 1H, NH), 8.27 (s, 1H, CH-azole), 7.67 (dd, J = 8.0 Hz and 1.2 Hz, 2H,
CH-benzene), 7.53 (t, J = 7.6 Hz, 2H, CH-benzene), 7.38–7.36 (m, 5H), 7.34–7.30 (m, 2H), 7.18
(s, 2H), 3.12, (sept, 4H, J = 6.8 Hz, CH(CH3)2), 1.48 (d, J = 6.4 Hz, 12H, CH(CH3)2), 1.15 (d,
J = 6.8 Hz, 12H, CH(CH3)2). 13C‒{1H} NMR (100 MHz, CDCl3): δ (ppm) = 151.6 (Ccarbene), 146.6
(N–CAr), 134.7 (iPr-C), 130.4 (CAr), 130.3 (CAr), 128.9 (CAr), 128.8 (CAr), 126.0 (N–CH=CH–N), 125.3
(CAr), 124.1 (CAr), 28.7 (CH(CH3)2), 26.3 (CH(CH3)2), 23.1 (CH(CH3)2). HR-MS (ESI): calcd for
C35H43ClN5Pd [M–Cl–]+ 674.2242; found 674.2199. IR (KBr, cm−1): 3250, 2965, 2865, 1652, 1630,
1576, 1557, 1539, 1480, 1455, 1384, 1362, 1300, 1269, 1171, 1091, 1056, 1017, 970, 914, 805.
Anal. Calcd for [PdCl2(IPr)(4-phenyl-1H-1,2,3-triazole)] (C35H43Cl2N5Pd): C, 59.12; H, 6.10; N,
9.85%. Found: C, 59.44; H, 6.39; N, 9.65%.
2.2.2. [PdCl2(SIPr)(5-phenyl-1H-1,2,3-triazole)] (2)
The procedure yielded 130 mg (91%) of the product 2 as a yellow powder. 1H NMR (400 MHz,
CDCl3): δ (ppm) = 12.94 (s, 1H, NH), 8.23 (s, 1H, CH-azole), 7.65 (d, J = 6.8 Hz, 2H, CH-benzene),
7.43 (t, J = 7.6 Hz, 2H, CH-benzene), 7.35–7.30 (m, 7H), 4.11 (s, 4H, NCH2CH2 N), 3.55 (sept, 4H,
J = 6.8 Hz, CH(CH3)2), 1.55 (d, J = 6.8 Hz, 12H, CH(CH3)2), 1.29 (d, J = 7.2 Hz, 12H, CH(CH3)2).
13C‒{1H} NMR (100 MHz, CDCl3): δ (ppm) = 183.2 (Ccarbene), 147.4 (N–CAr), 134.9 (iPr-C), 130.2
(CAr), 129.6 (CAr), 128.9 (CAr), 128.8 (CAr), 125.9 (CAr), 124.5 (CAr), 53.8 (N–CH2CH2–N), 28.8
(CH(CH3)2), 26.8 (CH(CH3)2), 24.1 (CH(CH3)2). HR-MS (ESI): calcd for C35H45ClN5Pd [M − Cl−]+
676.2398; found 676.2379. IR (KBr, cm−1): 3151, 3067, 2968, 1640, 1589, 1566, 1480, 1464,
1410, 1383, 1372, 1310, 1277, 1237, 1204, 1175, 1120, 1085, 1061, 971, 929, 804. Anal. Calc.
for [PdCl2(SIPr)(4-phenyl-1H-1,2,3-triazole)] (C35H45Cl2N5Pd): C, 58.95; H, 6.36; N, 9.82%. Found:
C, 58.65; H, 6.16; N, 9.65%.
2.3. Preparation of the dinuclear NHC–Pd complexes 3 and 4
A mixture of [Pd(μ-Cl)(Cl)(NHC)]2 (0.10 mmol, 113 mg), 4-phenyl-1H-1,2,3-triazole (0.10 mmol,
14.5 mg), and Et3N (0.20 mmol, 21 mg) were stirred in THF (5.0 mL) under reflux for 6 h to
give a yellow solution. After cooling, the solvent was reduced to about 1.0 mL, the resulting
residue was washed with diethyl ether (10.0 mL) and recrystallized from n-hexane/CH2Cl2
to give the dinuclear NHC–Pd complexes.
2.3.1. [Pd2(μ-Cl)(μ-4-phenyl-1H-1,2,3-triazole)Cl2(IPr)2] (3)
The procedure yielded 105 mg (85%) of the product 3 as a yellow powder. 1H NMR (400 MHz,
CDCl3) δ (ppm) = 7.93 (s, 1H, CH-azole), 7.55–7.53 (m, 2H), 7.51–7.46 (m, 4H), 7.35 (d, J = 6.4 Hz,
2H, CH-benzene), 7.28–7.25 (m, 6H), 7.22 (dd, J = 8.0 Hz and 1.2 Hz, 2H, CH-benzene), 7.18
(br, 3H), 7.08 (s, 2H, NCH=CHN), 3.43 (sept, J = 6.8 Hz, 2H, CH(CH3)2), 3.08 (sept, J = 6.8 Hz, 2H,
CH(CH3)2), 2.78 (sept, J = 6.8 Hz, 4H, CH(CH3)2), 1.41 (m, 12H, CH(CH3)2), 1.31 (d, J = 6.4 Hz, 6H,
CH(CH3)2), 1.12 (d, J = 6.8 Hz, 6H, CH(CH3)2), 1.02 (d, J = 7.2 Hz, 12H, CH(CH3)2), 0.88
(d, J = 6.8 Hz, 6H, CH(CH3)2), 0.30 (d, J = 6.4 Hz, 6H, CH(CH3)2). 13C‒{1H} NMR (100 MHz, CDCl3):
δ (ppm) = 156.7 (trans-Ccarbene), 154.7 (cis-Ccarbene), 147.4 (N–CAr), 146.4 (N–CAr), 146.2 (Cazole),
143.8 (Cazole), 135.1 (iPr-CAr), 134.4 (iPr-CAr), 131.7 (Cazole-Ar), 130.1 (CAr), 130.1 (CAr), 129.9 (CAr),
128.3 (CAr), 126.8 (CAr), 125.2 (N–CH=CH–N), 124.9 (N–CH=CH–N), 124.5 (Cazole-Ar), 124.4
(Cazole-Ar), 124.0 (CAr), 123.8 (CAr), 28.9 (CH(CH3)2), 28.6 (CH(CH3)2), 27.4 (CH(CH3)2), 26.6